Navamedic welcomes new shareholders Publisert: 13.03.2024 Navamedic ASA: Notification of major shareholding and mandatory notification of trade Publisert: 12.03.2024 Navamedic ASA: Mandatory notification of trade Publisert: 22.02.2024 Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives Publisert: 15.02.2024 Navamedic ASA: Invitation to 2023 4th quarter presentation Publisert: 13.02.2024 Navamedic ASA launches Eroxon® Publisert: 12.02.2024 FørsteForrige1718192021NesteSiste
Navamedic ASA: Notification of major shareholding and mandatory notification of trade Publisert: 12.03.2024
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives Publisert: 15.02.2024